Randomized double blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation.

8.6 (4.8) in the placebo group) but this just failed to reach statistical significance ( p = 0.05) ( Figure 3(a) to ( c )).

also in 203 other papers

The number of complete spontaneous bowel movements showed numerically higher value on active group at each week of supplementation period but this did not reach statistical significance.

also in 111,027 other papers